2021 Multiple Sclerosis & AUTOIMMUNE - Mayo

LEARNING OBJECTIVES Upon conclusion of this program, participants should be able to: Cite the mechanism of action, indications, and adverse events associated with recently-approved MS and autoimmune neurology disease-modifying therapies Describe the clinical, laboratory and neuroimaging characteristics of neuromyelitis optica spectrum disorders ................
................